Advisor Group Inc. increased its position in shares of Cardinal Health Inc (NYSE:CAH) by 141.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 72,866 shares of the company’s stock after buying an additional 42,672 shares during the quarter. Advisor Group Inc.’s holdings in Cardinal Health were worth $4,464,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the stock. Steward Partners Investment Advisory LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at approximately $102,000. Ffcm LLC purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $105,000. JNBA Financial Advisors grew its stake in shares of Cardinal Health by 615.4% in the 4th quarter. JNBA Financial Advisors now owns 1,860 shares of the company’s stock valued at $114,000 after purchasing an additional 1,600 shares during the last quarter. Cerebellum GP LLC purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $129,000. Finally, James Hambro & Partners purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $138,000. Hedge funds and other institutional investors own 90.04% of the company’s stock.
CAH has been the topic of several analyst reports. Robert W. Baird reiterated a “hold” rating and issued a $80.00 target price on shares of Cardinal Health in a research note on Wednesday, January 17th. Mizuho set a $73.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Wednesday, January 24th. Royal Bank of Canada set a $83.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Thursday, February 8th. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, Argus downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, November 15th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $74.78.
Shares of Cardinal Health Inc (NYSE CAH) opened at $72.36 on Tuesday. The company has a quick ratio of 0.57, a current ratio of 1.09 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $22,394.54, a P/E ratio of 12.58, a PEG ratio of 1.60 and a beta of 0.95. Cardinal Health Inc has a 1-year low of $54.66 and a 1-year high of $84.88.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, February 8th. The company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.14 by $0.17. The business had revenue of $35.19 billion during the quarter, compared to analysts’ expectations of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the firm earned $1.34 EPS. sell-side analysts anticipate that Cardinal Health Inc will post 5.42 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Sunday, April 15th. Investors of record on Monday, April 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date is Thursday, March 29th. This represents a $1.85 annualized dividend and a yield of 2.56%. Cardinal Health’s dividend payout ratio is presently 32.17%.
Cardinal Health declared that its Board of Directors has initiated a stock repurchase program on Thursday, February 8th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/03/13/advisor-group-inc-grows-position-in-cardinal-health-inc-cah.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.